Literature DB >> 33347712

Sample size calculations for single-arm survival studies using transformations of the Kaplan-Meier estimator.

Kengo Nagashima1, Hisashi Noma2, Yasunori Sato3, Masahiko Gosho4.   

Abstract

In single-arm clinical trials with survival outcomes, the Kaplan-Meier estimator and its confidence interval are widely used to assess survival probability and median survival time. Since the asymptotic normality of the Kaplan-Meier estimator is a common result, the sample size calculation methods have not been studied in depth. An existing sample size calculation method is founded on the asymptotic normality of the Kaplan-Meier estimator using the log transformation. However, the small sample properties of the log transformed estimator are quite poor in small sample sizes (which are typical situations in single-arm trials), and the existing method uses an inappropriate standard normal approximation to calculate sample sizes. These issues can seriously influence the accuracy of results. In this paper, we propose alternative methods to determine sample sizes based on a valid standard normal approximation with several transformations that may give an accurate normal approximation even with small sample sizes. In numerical evaluations via simulations, some of the proposed methods provided more accurate results, and the empirical power of the proposed method with the arcsine square-root transformation tended to be closer to a prescribed power than the other transformations. These results were supported when methods were applied to data from three clinical trials.
© 2020 John Wiley & Sons Ltd.

Keywords:  Kaplan-Meier estimator; confidence intervals; one sample test; sample size; survival analysis

Year:  2020        PMID: 33347712     DOI: 10.1002/pst.2090

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  4 in total

1.  Survival analysis in cancer patients with hyponatremia: effectiveness of tolvaptan treatment.

Authors:  Tomoyuki Kawada
Journal:  Int Urol Nephrol       Date:  2022-03-26       Impact factor: 2.266

2.  Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.

Authors:  Mikyoung Park; Mina Hur; Hanah Kim; Chae Hoon Lee; Jong Ho Lee; Hyung Woo Kim; Minjeong Nam
Journal:  Ann Lab Med       Date:  2022-07-01       Impact factor: 4.941

3.  Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study.

Authors:  Takaya Yamamoto; Yu Katagiri; Yoko Tsukita; Haruo Matsushita; Rei Umezawa; Yoshiyuki Katsuta; Noriyuki Kadoya; Noriyoshi Takahashi; Yu Suzuki; Kazuya Takeda; Keita Kishida; So Omata; Eisaku Miyauchi; Ryota Saito; Keiichi Jingu
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

4.  Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations.

Authors:  Daniel Gallacher; Peter Kimani; Nigel Stallard
Journal:  Pharmacoeconomics       Date:  2021-09-28       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.